Sean A. McCarthy, D. Phil.

Sean A. McCarthy, D. Phil.

Chief Executive Officer and Chairman of the Board of DirectorsatCytomX Therapeutics· In proxies 2022–2025

Pay in FY2025+170% from the year before · CytomX Therapeutics stock +313.6% the same year

Sean A. McCarthy, D. Phil. was paid $4.7M in FY2025 (Dec), up 170%. CytomX Therapeutics stock rose 313.6% that year.

Pay$100 in the stock at the end of FY21 → $102
Pay is from the Summary Compensation Table of each CytomX Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CytomX TherapeuticsPublic company · 4 yr
    • Chief Executive Officer and Chairman of the Board of Directors2022 – Present · 4 yrStock in role -44%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?